Clinical trial
Effect of Fasting on the Size of Lymphangioleiomyomas in Patients With Lymphangioleiomyomatosis
NCT00552955 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Fasting on the Size of Lymphangioleiomyomas in Patients With Lymphangioleiomyomatosis
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 26, 2007
- Completion date
- March 21, 2016
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lymphangioleiomyomas, lymphangioleiomyomatosis, tuberous sclerosis